Chemours Shares Outstanding vs. EBITDA
| CC Stock | USD 23.74 0.19 0.79% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.26 | 0.2175 |
|
|
For Chemours profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Chemours to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Chemours Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Chemours's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Chemours Co over time as well as its relative position and ranking within its peers.
Chemours |
Chemours' Revenue Breakdown by Earning Segment
Check out Trending Equities.
Is Diversified Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Dividend Share 1 | Earnings Share (2.22) | Revenue Per Share 39.222 | Quarterly Revenue Growth (0.12) |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Chemours EBITDA vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Chemours's current stock value. Our valuation model uses many indicators to compare Chemours value to that of its competitors to determine the firm's financial worth. Chemours Co is rated third in shares outstanding category among its peers. It also is rated third in ebitda category among its peers totaling about 1.48 of EBITDA per Shares Outstanding. At present, Chemours' EBITDA is projected to decrease significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chemours' earnings, one of the primary drivers of an investment's value.Chemours EBITDA vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Chemours |
| = | 148.9 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Chemours |
| = | 220 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Chemours EBITDA Comparison
Chemours is currently under evaluation in ebitda category among its peers.
Chemours Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Chemours, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Chemours will eventually generate negative long term returns. The profitability progress is the general direction of Chemours' change in net profit over the period of time. It can combine multiple indicators of Chemours, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -274 M | -287.7 M | |
| Operating Income | -87 M | -82.7 M | |
| Income Before Tax | -318 M | -302.1 M | |
| Total Other Income Expense Net | -231 M | -219.4 M | |
| Net Loss | -238 M | -226.1 M | |
| Income Tax Expense | -81 M | -77 M | |
| Net Income Applicable To Common Shares | 520.2 M | 355.7 M | |
| Net Loss | -237 M | -225.2 M | |
| Interest Income | 97.2 M | 131.1 M | |
| Non Operating Income Net Other | 118.8 M | 70.6 M | |
| Net Interest Income | -208 M | -218.4 M | |
| Change To Netincome | -11.5 M | -12.1 M | |
| Net Loss | (1.60) | (1.52) | |
| Income Quality | (2.34) | (2.22) | |
| Net Income Per E B T | 0.75 | 0.53 |
Chemours Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Chemours. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Chemours position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Chemours' important profitability drivers and their relationship over time.
Use Chemours in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.Chemours Pair Trading
Chemours Co Pair Trading Analysis
The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.
The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Chemours position
In addition to having Chemours in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Aggressive Funds Thematic Idea Now
Aggressive Funds
Funds or Etfs that attempt to achieve high capital gains by investing in companies with high growth potential and above average risk. The Aggressive Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Information and Resources on Investing in Chemours Stock
When determining whether Chemours offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chemours' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chemours Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chemours Co Stock:Check out Trending Equities. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
To fully project Chemours' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Chemours at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Chemours' income statement, its balance sheet, and the statement of cash flows.